channel blockers has been attributed to hemodynamic changes and to poorly defined direct tubular effects. To test the possibility that verapamil may inhibit Na ϩ reabsorption at the distal tubule, its effect on transepithelial Na ϩ transport in aldosterone-stimulated A6 cells was determined. Cells were grown on permeable supports, and short-circuit current (I sc) measured in an Ussing chamber was used as a surrogate marker for transepithelial Na ϩ transport. Application of 300 M verapamil to the apical side inhibited I sc by 77% and was nearly as potent as 100 M amiloride, which inhibited I sc by 87%. Verapamil-induced inhibition of Isc was accompanied by a significant increase in transepithelial resistance, suggesting blockade of an apical conductance. Its action on transepithelial Na ϩ transport does not appear to occur through inhibition of L-type Ca 2ϩ channels, since Isc was unaffected by removal of extracellular Ca 2ϩ . Verapamil also does not appear to inhibit I sc by modulating intracellular Ca 2ϩ stores, since it fails to inhibit transepithelial Na ϩ transport when added to the basolateral side. The effect on Na ϩ transport is specific for verapamil, since nifedipine, Ba 2ϩ , 4-aminopyridine, and charybdotoxin do not significantly affect I sc. A direct effect of verapamil on the epithelial Na ϩ channel (ENaC) was tested using oocytes injected with the ␣-, ␤-, and ␥-subunits. We conclude that verapamil inhibits transepithelial Na ϩ transport in A6 cells by blocking ENaC and that the natriuresis observed with administration of verapamil may be due in part to its action on ENaC.
verapamil; epithelial sodium channel; Xenopus laevis oocyte; sodium excretion and regulation; diuretic; natriuresis; A6 cells CALCIUM CHANNEL BLOCKERS are used extensively in the treatment of hypertension. They lower blood pressure by relaxing vascular smooth muscle and decreasing peripheral vascular resistance. Vasorelaxation is a result of blocking Ca 2ϩ entry through voltage-gated Ca 2ϩ channels. Ca 2ϩ channel blockers also have significant effects on heart rate and renal function. They increase renal blood flow and glomerular filtration rate and decrease the activity of the renin-angiotensin-aldosterone system and the reabsorption of salt and water (4, 6, 10) .
Although the natriuretic and diuretic effect of Ca 2ϩ channel blockers is in part due to changes in renal hemodynamics, direct tubular actions have also been well documented. The dihydropyridine class of Ca 2ϩ channel blockers has been studied most extensively. Intrarenal infusion of nifedipine significantly increased Na ϩ excretion without any detectable change in renal blood flow, creatinine clearance, and glomerular filtration rate (7) . These effects are thought to result from a decrease in Na ϩ reabsorption in the proximal tubule. On the other hand, felodipine, another dihydropyridine, appears to increase Na ϩ excretion by blocking reabsorption at a distal tubular site (6) . Verapamil, a phenylalkylamine, causes natriuresis when injected into the renal artery of the dog (1). Renal Na ϩ excretion is also significantly enhanced in hypertensive patients treated with verapamil (5, 10).
The molecular mechanisms underlying the tubular effects of Ca 2ϩ channel blockers are unclear. Na ϩ reabsorption occurs all along the nephron, and inhibition at any site could account for the modest degree of natriuresis observed with these agents. The collecting duct is an important site for Na ϩ homeostasis. In this nephron segment, principal cells are responsible for Na ϩ reabsorption. The rate-limiting step is the apical entry of Na ϩ through the epithelial Na ϩ channel (ENaC) (2) . This process is regulated by mineralocorticoids and plays a critical role in overall Na ϩ balance. The A6 cell line, derived from the Xenopus laevis kidney, possesses many of the properties of principal cells and has been used extensively as a model for the study of electrogenic transepithelial Na ϩ transport. When grown on permeable supports, these cells develop a high transepithelial resistance (TER), express the ENaC, and engage in transepithelial electrogenic Na ϩ transport that is regulated by insulin, aldosterone, and antidiuretic hormone. A6 cells and X. laevis oocytes expressing ENaC were used in the present study to examine the possibility that Ca 2ϩ channel blockers exert their natriuretic effect by inhibiting Na ϩ transport in the cortical collecting duct (CCD).
MATERIALS AND METHODS
Cell culture. A6 cells were plated and maintained in culture as previously described (9) . Briefly, cells were seeded at a density of 1 ϫ 10 6 cells/cm 2 on permeable supports in DMEM modified for amphibian culture and supplemented with 10% fetal bovine serum. They were grown in a humidified atmosphere of 2% CO 2 at 28°C. Aldosterone (1.5 M) was added for 2 days after the initial seeding and then for 18 h before measurements.
Solution and drugs. Unless stated otherwise, the apical and basolateral solutions were identical and consisted of 97 mM NaCl, 1 mM CaCl 2, 1 mM KCl, 0.5 mM MgCl2, and 5 mM HEPES (pH 7.2). For Ca 2ϩ -free solutions, CaCl2 was omitted and 1 mM EGTA was added. Where indicated, Ba 2ϩ was added as BaCl2. Verapamil and nifedipine were dissolved in 100% DMSO and added from 100 mM stock. The final DMSO concentration was Ͻ0.1%. In control studies, we ascertained that 0.1% DMSO added for up to 1 h to the apical membrane of A6 cells had no effect on short-circuit current (I sc ϭ 15.7 Ϯ 1.3 A, n ϭ 4). Similarly, 0.1% DMSO did not affect ENaC current measured in oocytes at Ϫ80 mV (current ϭ Ϫ2.1 Ϯ 0.2 A, n ϭ 4). For dose-response experiments, drugs were added to the apical or basolateral compartment in increasing concentrations. The inhibition constant (K i) for verapamil was calculated from the best logistic fit of the dose response. Values are means Ϯ SE.
Electrical measurements in A6 cells. Falcon inserts were mounted on plastic rings (effective surface area ϭ 0.64 cm 2 ) and placed in an Ussing chamber modified to allow continuous independent perfusion of apical and basolateral compartments. The compartments were connected by 1 M KCl-2% agar bridges. Current and transepithelial potential were measured using Ag-AgCl half-cells and a current-voltage clamp (model DVC-1000, WPI). Current flowing from the apical to the basolateral side was measured as positive by convention. The solution resistance was measured and compensated for before recordings began. I sc was measured by clamping the transepithelial voltage to 0 mV for 5 s. TER was calculated from the difference in current measured when the cells were voltage clamped to 0 or 60 mV, as follows:
Expression and measurement of ENaC current in X. laevis oocytes. Stage V-VI X. laevis oocytes were dissected from ovarian lobes and stored in modified Barth's solution, as previously described. Oocytes were injected with 50 nl of solution containing either a mixture of in vitro-transcribed, 5Ј-capped ␣-, ␤-, and ␥-ENaC RNA or water as a negative control.
Whole cell currents were recorded using a standard twomicroelectrode voltage clamp (model OC-725, Warner Instruments) 1-8 days after injection. Oocytes were impaled with microelectrodes filled with 1 M KCl (resistance ϭ 1-4 M⍀). The bath contained Na ϩ (or Li ϩ )-ND-96: 96 mM NaCl (or LiCl), 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES (pH 7.4). Voltage-clamp protocols were controlled by PULSE (HEKA Lambretch), and amplified currents were filtered at 1-2 kHz and then recorded and analyzed using PULSE-FIT (HEKA Lambretch) and Igor-Pro (Wavemetrics).
RESULTS AND DISCUSSION

Effect of verapamil on transepithelial Na
ϩ transport (I sc ). I sc is used as a surrogate marker for transepithelial Na ϩ transport in A6 cells, because ϳ90% of the current is amiloride sensitive. We confirmed this for A6 cells grown on permeable supports and treated with aldosterone for 18 h before measurements. Under these conditions, 100 M amiloride inhibited I sc by 87.3 Ϯ 2% (n ϭ 4). Therefore, the amiloride-sensitive I sc correlates well with Na ϩ transport from the apical to the basolateral side through the ENaC.
The effect of verapamil on I sc (and, therefore, on Na ϩ transport) was tested on A6 cells mounted in an Ussing chamber. As shown in Fig. 1 , the effect of Ca 2ϩ removal on I sc was measured. Figure 1 shows that removal of apical Ca 2ϩ had no effect on I sc under control conditions and TER was unaffected. Furthermore, verapamil inhibited I sc to a similar degree in the absence and presence of Ca 2ϩ (Fig. 1) . Verapamil is lipophilic, so it penetrates the cell membrane and accumulates inside the cell. Therefore, it could inhibit Ca 2ϩ release from intracellular stores, which could in turn modulate I sc . To further rule out the possibility that verapamil's action on I sc might be Ca 2ϩ dependent, its inhibitory effect on I sc was compared with that of nifiedipine, a structurally unrelated, potent L-type Ca 2ϩ channel blocker. Although nifedipine is a significantly more potent blocker of L-type Ca 2ϩ channels than verapamil, it decreased I sc by only 7.3 Ϯ 0.3% when applied to the apical side at the highest concentration (200 M) achievable in aqueous media. Be- Fig. 1 . Verapamil inhibits transepithelial Na ϩ transport in A6 cells grown on permeable supports and treated with 1 M aldosterone 18 h before study. Monolayers were mounted in Ussing chambers, and short-circuit current (Isc) was measured by clamping to 0 mV for 5 s. Apical Ca 2ϩ concentration was 0 or 1 mM. Verapamil (Vera) was added to apical or basolateral perfusate.
cause, as shown in Fig. 1, 0. 2 mM verapamil added to the basolateral side has no significant effect on I sc , we conclude that the drug inhibits I sc and Na ϩ transport only when applied to the apical side and through a mechanism unrelated to its action on plasma membrane L-type Ca 2ϩ channels and intracellular Ca 2ϩ stores.
Effect of verapamil on TER.
It is possible that verapamil could inhibit I sc and yet cause no change in net Na ϩ transport. Indeed, if addition of the drug leads to a nonspecific decrease in TER, through interaction with the paracellular junction or by damaging the plasma membrane, transepithelial voltage and I sc would be expected to decrease independently of a net decrease in Na ϩ transport. If that were the case, the inhibition of I sc would be accompanied by a fall in membrane resistance. For instance, diltiazem is known to increase the permeabilities of anions and cations in photoreceptor rod outer segments and in intact red blood cells (3). To exclude this possibility, the effect of verapamil on membrane resistance was determined from the change in monolayer current resulting from a 60-mV voltage step. As shown in Fig. 2 , control cells had a TER of 2,575 Ϯ 350 ⍀ ⅐ cm 2 (n ϭ 11). Increasing concentrations of verapamil from 100 to 400 M led to progressive increases in TER (5,002 Ϯ 406 ⍀ ⅐ cm 2 , n ϭ 5). These results indicate that the fall in I sc observed with the addition of verapamil does not occur because of nonspecific changes in the paracellular junction or damage to the cell membranes. Instead, verapamil appears to have a direct inhibitory effect on transepithelial Na ϩ transport.
Dose-dependent inhibition of Na
ϩ transport by verapamil. The dose-response curve for verapamil with respect to inhibition of I sc in A6 cells was determined by adding increasing concentrations of the drug to the apical side. The amiloride-sensitive component of I sc was determined after each experiment by the addition of 100 M amiloride. As shown in Fig. 3 , the K i of I sc for verapamil is 104.5 M.
Verapamil contains a nitrogen at position 9 that undergoes pH-dependent protonation (pK a ϭ 8.5). The nonprotonated form of verapamil is lipophilic and readily penetrates biological membranes. Figure 4 shows that the effect of verapamil is strongly influenced by the pH of the apical perfusate. As pH increases from 5 to 8, verapamil becomes deprotonated and its potency to block I sc increases. Indeed, verapamil predominantly blocks L-type Ca 2ϩ and K ϩ channels from the cytoplasmic side (13) . It is likely that verapamil also inhibits I sc from the cytoplasmic side, since, as observed for inhibition of Ca 2ϩ and K ϩ channels, its onset of action on I sc is delayed (3-4 min) and slowly reaches a plateau within 10-15 min. Therefore, the true K i for verapamil-induced inhibition of I sc cannot be determined without measuring the intracellular concentration of the drug.
Effect of nifedipine and K ϩ channel blockers on Na ϩ transport. Verapamil is also known to inhibit voltagegated K ϩ channels, such as Kv1.3 and KCNA10 (K i ϭ 50 M). Therefore, it is possible that it could mediate its effect on transepithelial Na ϩ transport by blocking K ϩ channels. This possibility was tested by examining the effect of K ϩ channel blockers applied to the apical side of A6 cells. Ba 2ϩ (10 mM), which inhibits a variety of K ϩ channels, caused only a small decrease in I sc ( Amiloride-sensitive component was determined by addition of 100 M amiloride at the end of each experiment. Percent inhibition of amiloride-sensitive current was determined at each concentration (n ϭ 4 for each data point). Data were fitted using Origin 6.0. Ki, concentration for 50% inhibition.
tively) had no detectable effect on I sc and Na ϩ transport. Nifedipine, a dihydropyridine Ca 2ϩ channel blocker chemically unrelated to verapamil, blocks Na ϩ channels in rat cardiac myocytes with a K i of 3.0 M (12). Its effect on I sc in A6 cells was tested, and, as shown in Fig. 5 , it was ineffective at blocking I sc at the highest concentration achievable in aqueous media (0.2 mM). The inability of nifedipine to block I sc supports the conclusion that the effect of verapamil on I sc is independent of its action on L-type Ca 2ϩ channels. These data also indicate that verapamil is a specific inhibitor of transepithelial Na ϩ transport in A6 cells and that its mechanism of action does not depend on the inhibition of K ϩ channels. Effect of verapamil on ENaC in X. laevis oocytes. We considered the possibility that verapamil directly blocks ENaC. Indeed, its chemical structure resembles that of two inhibitors of ENaC, namely, trimethoprim and benzamil. To test that hypothesis, cRNA for ␣-, ␤-, and ␥-ENaC were coinjected into X. laevis oocytes, and the effect of verapamil on amiloride-sensitive inward current was examined using the two-microelectrode voltage-clamp method. Figure 6 depicts a representative experiment in which membrane voltage is clamped from Ϫ80 to ϩ40 mV in 10-mV increments and the resulting current is measured. In oocytes expressing ENaC, 85.1 Ϯ 3% (n ϭ 4) of the current measured at Ϫ80 mV was amiloride sensitive and mediated by ENaC. Verapamil inhibited amiloride-sensitive current with a K i of 34 Ϯ 5.2 M (n ϭ 4). The K i observed in oocytes is similar to that measured in A6 cells, supporting the notion that ENaC inhibition underlies the effect of verapamil on I sc .
The data presented above confirm the hypothesis that verapamil inhibits ENaC. It is not clear whether the drug inhibits from the cytoplasmic side, since, although the slow time course of inhibition and its dependence on external pH suggest that it does, its inability to block when added to the basal side argues otherwise. The latter observation does not completely rule out the possibility of blocks from the inside, since it is not known whether verapamil that enters from the basolateral side freely diffuses to the apical side.
Physiological relevance. On the basis of studies examining the urinary concentration of verapamil and its metabolites, ϳ5% of the dose of verapamil administered is excreted unchanged in the urine over 24 h (8) . With a maximum daily dose of 500 mg, distal tubular fluid may contain 25 mg/l verapamil or ϳ50 M. The data in the present study suggest that this concentration would be sufficient to exert a significant effect on Na ϩ transport through inhibition of ENaC. It should be noted, however, that inhibition of I sc by verapamil was greater at alkaline than acidic pH. The pH at the distal tubule can be as low as 5.5 and would predict a significant decrease in the inhibitory potency of verapamil. On the other hand, verapamil tends to accumulate in cells, and the steady-state intracellular concentration at distal tubular cells might be even higher than expected from a luminal concentration of 50 M.
Conclusion. The present study shows that verapamil, unlike nifedipine, inhibits Na ϩ reabsorption in A6 cells, a cell model for the principal cells of the CCD. The concentration of verapamil thought to be present in distal tubular fluid is more than sufficient to cause significant inhibition of Na ϩ reabsorption through ENaC. Therefore, the natriuresis observed with the administration of verapamil is likely mediated by a combination of hemodynamic factors and the direct tubular effect demonstrated in this study. The present study documents a previously unrecognized amiloridelike effect of verapamil on Na ϩ transport in A6 cells and a direct inhibitory effect of the drug on ENaC. We speculate that the antihypertensive action of verapamil results from a combination of a direct effect on http://ajprenal.physiology.org/ vascular smooth muscle and a small but significant decrease in total body Na ϩ stores through its action on Na ϩ reabsorption in the CCD. It may be possible to improve the efficacy and safety profile of verapamil and develop analogs with enhanced natriuretic properties.
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